Concepedia
Statistics
Publications
7
Citations
483
H-Index
Active since
2012
Affiliations
Jilin University(Current)
Union Hospital
LI Chang-feng is an author at Jilin University specializing in tumor biology, medicine, and cancer research.
Top concepts
MedicineCell BiologyTumor BiologyCancer ResearchOncologyPathologyCancer Cell BiologyCancer BiologyColorectal CancerRadiation Oncology
Publications per year
2012–2020
LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling.
Dayong Ding, LI Chang-feng, Tiancheng Zhao et al. · PubMed · 2018 · 181 citations · Full text
A novel circFMN2 promotes tumor proliferation in CRC by regulating the miR-1182/hTERT signaling pathways
Yongchao Li, LI Chang-feng, Ruisi Xu et al. · Clinical Science · 2019 · 88 citations · Full text
Procaine is a specific DNA methylation inhibitor with anti‐tumor effect for human gastric cancer
Y Y Li, Yun Wang, Dandan Li et al. · Journal of Cellular Biochemistry · 2017 · 68 citations
Histone Modifications, Epigenetic Change, Dna Methylation +27
The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer
Ruisi Xu, Xiaodong Wu, Siqi Zhang et al. · International Journal of Oncology · 2012 · 61 citations · Full text
Tumor Biology, Oncology, Human Colon Cancer +12
The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma
LI Chang-feng, Yongchao Li, Yun Wang et al. · Cellular Physiology and Biochemistry · 2018 · 55 citations · Full text
1–5 of 7